Mytrate
Brand names,
Mytrate
Analogs
Mytrate
Brand Names Mixture
Mytrate
Chemical_Formula
C9H13NO3
Mytrate
RX_link
http://www.rxlist.com/cgi/generic3/epi.htm
Mytrate
fda sheet
Mytrate
msds (material safety sheet)
Mytrate
Synthesis Reference
Stolz, Ber. 37, 4149; Payne, Ind. Chem. 37, 523
Mytrate
Molecular Weight
183.204 g/mol
Mytrate
Melting Point
211.5 oC
Mytrate
H2O Solubility
180 mg/L
Mytrate
State
Solid
Mytrate
LogP
0.256
Mytrate
Dosage Forms
Cord; Drops; Liquid; Metered-dose (aerosol); Pad; Pellet; Pellet (dental); Solution; Spray
Mytrate
Indication
For the treatment of anaphylactic reactions
Mytrate
Pharmacology
Epinephrine is indicated for intravenous injection in treatment of acute hypersensitivity, treatment of acute asthmatic attacks to relieve bronchospasm, and treatment and prophylaxis of cardiac arrest and attacks of transitory atrioventricular heart block with syncopal seizures (Stokes-Adams Syndrome). The actions of epinephrine resemble the effects of stimulation of adrenergic nerves. To a variable degree it acts on both alpha and beta receptor sites of sympathetic effector cells. Its most prominent actions are on the beta receptors of the heart, vascular and other smooth muscle. When given by rapid intravenous injection, it produces a rapid rise in blood pressure, mainly systolic, by (1) direct stimulation of cardiac muscle which increases the strength of ventricular contraction, (2) increasing the heart rate and (3) constriction of the arterioles in the skin, mucosa and splanchnic areas of the circulation. When given by slow intravenous injection, epinephrine usually produces only a moderate rise in systolic and a fall in diastolic pressure. Although some increase in pulse pressure occurs, there is usually no great elevation in mean blood pressure. Accordingly, the compensatory reflex mechanisms that come into play with a pronounced increase in blood pressure do not antagonize the direct cardiac actions of epinephrine as much as with catecholamines that have a predominant action on alpha receptors.
Mytrate
Absorption
Usually this vasodilator effect of the drug on the circulation predominates so that the modest rise in systolic pressure which follows slow injection or absorption is mainly the result of direct cardiac stimulation and increase in cardiac output.
Mytrate
side effects and Toxicity
Skin, LD50 = 62 mg/kg (rat)
Mytrate
Patient Information
No information avaliable
Mytrate
Organisms Affected
Humans and other mammals